Literature DB >> 4093900

Plasma fibrinogen--a major coronary risk factor.

M C Stone, J M Thorp.   

Abstract

The role of plasma fibrinogen as a potential indicator of susceptibility to heart attacks was studied in a sample of 297 men aged 40-69 years at entry who were initially free from overt coronary heart disease. During a mean observation period of 7.3 years (range 0.1-16.1) new heart attacks occurred in 40 men. There was a significant positive correlation between initial plasma fibrinogen levels and the subsequent incidence of heart attacks. In men with high cholesterol or high systolic blood pressure levels the incidence of heart attacks was respectively six times and 12 times greater in those with high plasma fibrinogen levels than in those with low fibrinogen levels. In multivariate models plasma fibrinogen was a highly significant and independent explanatory variable, at least as important as serum cholesterol, blood pressure or cigarette smoking. These results suggest that high plasma fibrinogen levels are an important coronary risk factor and should be included in profiles used to identify those at high risk of heart attacks.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4093900      PMCID: PMC1961456     

Source DB:  PubMed          Journal:  J R Coll Gen Pract        ISSN: 0035-8797


  17 in total

Review 1.  Fibrin(ogen), platelets and a new theory of atherogenesis.

Authors:  A L Copley
Journal:  Thromb Res       Date:  1979 Feb-Mar       Impact factor: 3.944

2.  Comparison of membrane filtration and nephelometry with analytical ultracentrifugation, for the quantitative analysis of low density lipoprotein fractions.

Authors:  M C Stone; J M Thorp; G L Mills; T B Dick
Journal:  Clin Chim Acta       Date:  1970-12       Impact factor: 3.786

3.  Hepatocyte-stimulating factor: a monocyte-derived acute-phase regulatory protein.

Authors:  D G Ritchie; G M Fuller
Journal:  Ann N Y Acad Sci       Date:  1983-06-27       Impact factor: 5.691

4.  Direct determination of plasma fibrinogen levels by heat precipitation. A comparison of the technique against thrombin clottable fibrinogen with spectrophotometry and radial immuno-diffusion.

Authors:  P Desvignes; P Bonnet
Journal:  Clin Chim Acta       Date:  1981-02-19       Impact factor: 3.786

5.  Erythrocyte-sedimentation rate before and after in-vitro defibrination: A rapid and simple method for increasing its specificity.

Authors:  G Holdstock; J R Mitchell
Journal:  Lancet       Date:  1977 Dec 24-31       Impact factor: 79.321

6.  Relation between extent of coronary artery disease and blood viscosity.

Authors:  G D Lowe; M M Drummond; A R Lorimer; I Hutton; C D Forbes; C R Prentice; J C Barbenel
Journal:  Br Med J       Date:  1980-03-08

7.  Haemostatic factors in human aortic intima.

Authors:  E B Smith; E M Staples
Journal:  Lancet       Date:  1981-05-30       Impact factor: 79.321

8.  Prevalence of hyperlipoproteinaemias in a random sample of men and in patients with ischaemic heart disease.

Authors:  M C Stone; T B Dick
Journal:  Br Heart J       Date:  1973-09

9.  Risk factors for myocardial infarction in the Stockholm prospective study. A 14-year follow-up focussing on the role of plasma triglycerides and cholesterol.

Authors:  L A Carlson; L E Böttiger; P E Ahfeldt
Journal:  Acta Med Scand       Date:  1979

10.  Haemostatic function and cardiovascular death: early results of a prospective study.

Authors:  T W Meade; W R North; R Chakrabarti; Y Stirling; A P Haines; S G Thompson; M Brozovié
Journal:  Lancet       Date:  1980-05-17       Impact factor: 79.321

View more
  52 in total

Review 1.  Pathogenesis and pathology of coronary heart disease syndromes.

Authors:  P M Ridker; E M Antman
Journal:  J Thromb Thrombolysis       Date:  1999-10       Impact factor: 2.300

2.  Genetic variation at fibrinogen loci and plasma fibrinogen levels.

Authors:  J M Connor; F G Fowkes; J Wood; F B Smith; P T Donnan; G D Lowe
Journal:  J Med Genet       Date:  1992-07       Impact factor: 6.318

3.  Comparison of an immunochemical assay for plasma fibrinogen and a turbidimetric thrombin clotting technique to discriminate hyperlipidaemic patients from healthy controls.

Authors:  M L Knapp; M D Feher; H Carey; P D Mayne
Journal:  J Clin Pathol       Date:  1990-06       Impact factor: 3.411

Review 4.  Coronary heart disease in diabetes mellitus--antecedents and associations.

Authors:  P H Winocour
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

Review 5.  Hypertension in non-insulin dependent diabetes mellitus and its management.

Authors:  M D Feher
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

6.  Fibrinogen.

Authors:  E Ernst
Journal:  BMJ       Date:  1991-09-14

7.  Modelling the Helsinki Heart Study by means of risk equations obtained from the PROCAM Study and the Framingham Heart Study.

Authors:  G Assmann; H Schulte
Journal:  Drugs       Date:  1990       Impact factor: 9.546

8.  Level of fibrinogen and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe.

Authors:  M L Bots; P C Elwood; J T Salonen; A Freire de Concalves; J Sivenius; A Di Carlo; Y Nikitin; V Benetou; J Tuomilehto; P J Koudstaal; D E Grobbee
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

9.  Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study.

Authors:  A J Lee; G D Lowe; M Woodward; H Tunstall-Pedoe
Journal:  Br Heart J       Date:  1993-04

Review 10.  Cardiovascular injury induced by tobacco products: assessment of risk factors and biomarkers of harm. A Tobacco Centers of Regulatory Science compilation.

Authors:  Daniel J Conklin; Suzaynn Schick; Michael J Blaha; Alex Carll; Andrew DeFilippis; Peter Ganz; Michael E Hall; Naomi Hamburg; Tim O'Toole; Lindsay Reynolds; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-01       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.